Browse > Article
http://dx.doi.org/10.4333/KPS.2011.41.5.263

Multi-Layered Matrix Tablets with Various Tablet Designs and Release Profiles  

Choi, Du-Hyung (College of Pharmacy, Pusan National University)
Jeong, Seong-Hoon (College of Pharmacy, Pusan National University)
Publication Information
Journal of Pharmaceutical Investigation / v.41, no.5, 2011 , pp. 263-272 More about this Journal
Abstract
Tablet dosage forms have been preferred over other formulations for the oral drug administration due to their low manufacturing costs and ease of administrations, especially controlled-release applications. Controlled-release tablets are oral dosage forms from which the active pharmaceutical ingredient (API) is released over an intended or extended period of time upon ingestion. This may allow a decrease in the dosing frequency and a reduction in peak plasma concentrations and hence improves patient compliance while reducing the risk of undesirable side effects. Conventional singlelayered matrix tablets have been extensively utilized to deliver APIs into the body. However, these conventional single-layered matrix tablets present suboptimal delivery properties, such as non-linear drug delivery profiles which may cause higher side effects. Recently, a multi-layered technology has been developed to overcome or eliminate the limitations of the singlelayered tablet with more flexibility. This technology can give a good opportunity in formulating new products and help pharmaceutical companies enhancing their life cycle management. In this review, a brief overview on the multi-layered tablets is given focusing on the various tablet designs, manufacturing issues and drug release profiles.
Keywords
Multi-layered tablets; Drug release; Matrix; Tablet design; Manufacturing;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sirkia, T., Niemi, J., Marvola, M., Lindqvist, T., Happonen, I., 1994b. Effect of potassium carbonate and viscosity grade of hydroxypropylmethylcellulose on the bioavailability of furosemide from press-coated prolonged-release tablets. STP Pharma Sci. 4, 257-263.
2 Smlensky, M.H., D'alanzo, G.E., 1993. Medical chronobiology: concepts and applications. Am. Rev. Respir. Dis. 147, s2-s19.   DOI
3 Streubel, A., Jsiepmann, A., Peppas, N.A., Bodmeier, R., 2000. Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. J. Control. Release 69, 455-468.   DOI
4 Takenchi, H., Yasuji, T., Yamamoto, H., Kawashima, Y., 2000. Spray dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry coated tablet having a time-controlled releasing function. Pharm. Res. 17, 94-99.   DOI
5 Vaithiyalingam, S.R., Sayeed, V.A., 2010. Critical factors in manufacturing multi-layer tablets-Assessing material attributes, inprocess controls, manufacturing process and product performance. Int. J. Pharm. 398, 9-13.   DOI
6 Wilding, I.R., Coupe, A.J., Davis, S.S., 1991. The role of gamma scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. 7, 87-117.   DOI
7 Wu, C.Y., Seville, J.P.K., 2009. A comparative study of compaction properties of binary and layered tablets. Powder Technol. 189, 285-294.   DOI
8 Yang, L., Venkatesh, G., Fassihi, R., 1997. Compaction simulator study of a novel triple-layer tablet matrix for industrial tabletting. Int. J. Pharm. 152, 45-52.   DOI
9 Zin El-Din, E., El-Shaboury, M.H., El-Aleem, H.A., 1989. Effect of tablet shape on the in vitro and in vivo availability of directly compressed non-disintegrating tablets. Pharm. Ind. 51, 694-696.
10 Podczeck, F., 2011. Theoretical and experimental investigations into the delamination tendencies of bilayer tablets. Int. J. Pharm. 408, 102-112.   DOI
11 Podczeck, F., Al-Muti, E., 2010. The tensile strength of bilayered tablets made from different grades of microcrystalline cellulose. Eur. J. Pharm. Sci. 41, 483-488.   DOI
12 Scott, D.C., Hollenbeck, R.G., 1991. Design and manufacture of zero-order sustained-release pellet dosage from through non uniform drug distribution in a diffusional matrix. Pharm. Res. 8, 156-162.   DOI
13 Reinberg, A.E., 1992. Concepts in chronopharmacology. Annu. Rev. Pharmacol. Toxicol. 32, 51-66.   DOI
14 Ritger, P.L., Peppas, N.A., 1987. A simple equation for the description of solute release: II. Fickian and anomalous release from swellable devices. J. Control. Release 5, 37-42.   DOI
15 Samuelov, Y., Donbrow, M., Friedman, M., 1979. Sustainedrelease of drugs from Ethyl cellulose-polyethylene glycol films and kinetics of drug release. J. Pharm. Sci. 68, 325-329.   DOI
16 Shah, A.C., 1987. Therapeutic formulations with bimodal release characteristics. W.O. Patent 87/00044, January 15.
17 Shah, A.C., Britten, N.J., 1990. Novel divisible design for sustained release formulations. J. Control. Release 14, 179-185.   DOI
18 Shah, A.C., Britten, N.J., Olanoff, L.S., Badalamenti, J.N., 1989. Gelmatrix system exhibiting bimodal controlled-release for oral drug delivery. J. Control. Release 9, 169-175.   DOI
19 Sirkia, T., Makimartti, M., Liukko-Sipe, S., Marvola, M., 1994a. Development and biopharmaceutical evaluation of a new press-coated prolonged-release salbutamol sulfate tablet in man. Eur. J. Pharm. Sci. 195-201.
20 Narisawa, S., Nagata, M., Danyoshi, C., Yoshino, H., Murata, K., Hirakawa, Y., Noda, K., 1994. An organic acid induced sigmoidal release systems for oral controlled-release preparations. Pharm. Res. 11(1), 111-116.   DOI
21 Otsuka, M., Matsuda, Y., 1995. Progrannable drug release of highly water-soluble pentoxifilline from drug-coated wax matrix tablets. J. Pharm. Sci. 84, 443-447.   DOI
22 Narasimhan, B., Langer, R., 1997. Zero-order release of micro and macromolecules from polymeric devices: the role of the burst effect. J. Control. Release 47, 13-20.   DOI
23 Nelson, K.G., Smith, S.J., Bennett, R.M., 1987. Constant-release diffusion systems: rate control by means of geometric configuration, in: P.I. Lee, W.R. Good (Eds.), Controlled-released Technology: Pharmaceutical Applications, Acs Symposium Series, vol. 348, American Chemical Society, Washington, DC, pp. 324-340.
24 Nirmal, J., Saisivam, S., Peddanna, C., Muralidharan, S., Nagarajan, M., et al., 2008. Bilayer tablets of atrovastatin calcium and nicotinic acid: formulation and evaluation. Chem. Pharm. Bull. 56, 1455-1458.   DOI
25 Peppas, N.A., 1988. Hydrogels in Medicine and Pharmacy, vols. I, II and III, CRC Press, Boca Raton, FL.
26 Peppas, N.A., Sahlin, J.J., 1989. A simple equation for the description of solute release: III. Coupling of diffusion and relaxation. Int. J. Pharm. 57, 169-172.   DOI
27 Phaechamud, T., 2008. Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose. AAPS PharmSciTech 9, 668-674.   DOI
28 Pozzi, F., Furlani, P., Gazzaniga, A., Davis, S.S., Wilding, I.R., 1994. The time clock system: a new oral dosage from for fast complete release of drug after a predetermined lagtime. Int. J. Pharm. 31, 99-108.
29 La Manna, A., Conte, U., Colombo, P., 1991. Physical restriction in swellable matrices as modulator of drug release, Eurobiomat Workshop on "Synthetic Polymer as Drug carriers. Interaction with blood." Pallanza, Italy, April 21-24.
30 Lee, L., 1992. Diffusion-controlled matrix systems, in: A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery, Marcel Dekker, New York, pp. 155-198.
31 Lee, P.I., 1985. Kinetics of drug release from the hydrogel matrices. J. Control. Release 2, 277-288.   DOI
32 Lemmer, N., 1996. The clinical relevance of chronopharmacology in therapeutics. Pharmacol. Res. 33, 107-115.   DOI
33 Lin, S.-Y., Lin, K.-H., Li, M.-J., 2001. Micronized ethyl cellulose used for designing a directly compressed time-controlled disintegration tablet. J. Control. Release 70, 321-328.   DOI
34 Lipper, R.A., Higuchi, W.I., 1977. Analysis of theoretical behavior of proposed zero-order drug delivery system. J. Pharm. Sci. 66, 163-164.   DOI
35 Maggi, L., Morgenthaler, S., Zimmer, R., Shepard, T., Conte, U., 1992. Human evaluation of Quick/Slow drug delivery technology: a new therapeutic approach, Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materials, Seattle, USA, July 31-August 2, pp. 208-209.
36 Maggi, L., Shepard, T., Rochdi, M., Grenier, P., Halbeisen, S., Zimmer, R., Conte, U., 1997. A simulation approach for efficient development of a naproxen Geomatrix Quick/Slow formulation, Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, June 15-19, pp. 327-328.
37 Matsuo, M., Nakamura, C., Arimori, K., Nakano, M., 1995. Evaluation for hydroxylethylcellulose as a hydrophilic swellable material for delayed-release tablets. Chem. Pharm. Bull. 43(2), 311-314.   DOI
38 Hsiesh, D.S.T., Rhine, W.D., Langer, R., 1983. Zero-order controlled-release polymer matrices from micro and macro molecules. J. Pharm. Sci. 72, 17-22.   DOI
39 Inman, S.J., Briscoe, B.J., Pitt, K.G., Shiu, C., 2009. The non-uniformity of microcrystalline cellulose bilayer tablets. Powder Technol. 188, 283-294.   DOI
40 Inman, S.J., Briscoe, B.J., Pitt, K.G., 2007. Topographic characterization of cellulose bilayered tablets interfaces. Chem. Eng. Res. Des. 85, 1005-1012.   DOI
41 Ishino, R., Yoshino, H., Hirakawa, Y., Noda, K., 1992. Design and preparations of pulsatile release tablet as a new oral drug delivery system. Chem. Pharm. Bull. 40, 3036-3041.   DOI
42 Junginger, H.L., 1993. Oral applications of pulsatile drug delivery, in: Gurny, R., Junginger, H.L., Peppas, N.A. (Eds.), Pulsative Drug Delivery-Current Application and Future Trends, Wissenschaftliche Verlagsagesellschaft, Stuttgart, pp. 113-134.
43 Karehill, P.G., Glaser, M., Nystrom, C., 1990. Studies on direct compression of tablets. XXIII. The importance of surface roughness for the compactability of some directly compressible materials with different bonding and volume reduction properties. Int. J. Pharm. 64, 35-43.   DOI
44 Kim, C., 1994. Compressed Donut-shaped tables with zero-order release kinetics. Pharm. Res. 12, 1045-1048.
45 Krishnaiah, W.S.R., Rama Ral, T., Ushasree, M., Satyanarayana, S., 2002. A study on the in-vitro evaluation of guar gum as a carrier for oral controlled drug delivery. Saudi Pharm. J. 9, 91-98.
46 Kulkarni, Bhatia, M., 2009. Development and evaluation of bilayer floating tablets of atenolol and lovastatin for biphasic release profile. Iran. J. Pharm. Res. 8, 15-25.
47 Conte, U., Maggi, L., Torre, M.L., Giunchedi, P., La Manna, A., 1993. Press-coated tablets for time-programmed release of drugs. Biomaterials 14, 1017-1023.   DOI
48 Ebey, G.C., 1996. Bilayer tablet weight control theory. In: Pharm. Tech., Tablet Granulation Year Book, pp. 54-57.
49 Danckwerts, M.P., 1994. Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int. J. Pharm. 112, 34-45.
50 Danielson, D.W., Morehead, W.T., Rippie, E.G., 1983. Unloading and post compression viscoelastic stress versus strain behavior of pharmaceutical solids. J. Pharm. Sci. 72, 342-345.   DOI
51 Efentakis, M., Peponaki, C., 2008. Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on carbopols with isosorbite mononitrate. AAPS PharmSciTech 9, 917-923.   DOI
52 Fukui, E., Miyamura, N., Kobayashi, M., 2001. An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J. Control. Release 70, 97-107.   DOI
53 Fukui, E., Uemura, L., Kobayashi, M., 2000. Studies on applicability of press-coated tablets using hydroxypropylcellulose in the outer shell for timed-release preparation. J. Control. Release 68, 215-223.   DOI
54 Halsas, M., Simelius, R., Kiviniemi, A., Veski, P., Jurjenson, H., Marvola, M., 1998. Effect of different combinations of hydroxypropylmethylcellulose and bioavailability of ibuprofen from press-coated time-controlled tablets. STP Pharm Sci. 8, 155-161.
55 Hildgen, D., McMullen, J.N., 1995. A new gradient matrix: formulation and characterization. J. Control. Release 34, 263-271.   DOI
56 Cobby, J., Mayersohn, M. and Walker, G.C., 1974b. Influence of shape factors on kinetics ofdrug release from matrix tablets. II: theoretical. J.Pharm.Sci.63: 732-737.   DOI
57 Conte, U., La Manna, A., Maggi, L., 1997. Controlled release pharmaceutical tablet having lenticular from. U.S. Patent 5,626,874, May 6.
58 Colombo, P., Conte, U., Gazzaniga, A., Maggi, L., Sangalli, M.E., Peppas, N.A., La Manna, A., 1990. Drug release modulation by physical restriction of matrix swelling. Int. J. Pharm. 63, 43-48.   DOI
59 Colombo, P., Gazzaniga, A., Caramella, C., Conte, U., La Manna, A., 1987. In vitro progragmmable zero-order release drug delivery systems. Acta Pharm. Technol. 33, 15-20.
60 Conte, U., La Manna, A., Maggi, L., 1995. Pharmaceutical tablets releasing the active substances after a definite period of time. U.S. patent 5,464,633, November 7.
61 Conte, U., Maggi, L., 1987. Geomatrix tablets for the pulsatile release of drugs, Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, June 15-19, pp. 291-292.
62 Conte, U., Maggi, L., 1998. Multilayer tablets as drug delivery devices. Pharm. Technol. 22(3), 174-182.
63 Conte, U., Maggi, L., 2000. A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets. J. Control. Release 64, 263-268.   DOI
64 Conte, U., Maggi, L., Colombo, P., La Manna, A., 1993. Multi-layered hydrophilic matrices as constant release devices ($Geomatrix^{TM}$ Systems). J. Control. Release 26, 39-47.   DOI
65 Conte, U., Maggi, L., Giunchedi, P., La Manna, A., 1992. New oral for timing release of drugs. Boll. Chim. Farm. 131(5), 198-204.
66 Benkorah, A.Y., McMullen, J.N., 1994. Biconcave coated, centrally perforated tablets for oral controlled drug delivery. J. Control. Release 32, 155-160.   DOI
67 Buri, P., Doelker, E., 1980. Formulation des comprimes a liberation prolengee: II. Matrices hydrophiles. Pharm. Acta. Helv. 7-8, 189-197.
68 Bidmeier, R., Paeratakul, O., 1990. Drug release form laminated polymeric films prepared from aqueous latexes. J. Pharm. Sci. 79, 32-36.   DOI
69 Bogan, R.K., 2008. Treatment options for insomnia-pharmacodynamics of zolpidem extended-release to benefit next-day performance. Postgrad. Med. 120, 161-171.   DOI
70 Brooke, D., Walshkuhn, R.J., 1977. Zero-order drug delivery system: theory and preliminary testing. J. Pharm. Sci. 66, 159-162.   DOI
71 Buri, P., Puisicux, F., Doelker, E., Benoit, J.P., 1985. Formes Pharmacentiques Nouvelles, Ed. Technique et Documentation, Lavoisier, Paris.
72 Busignies, V., Leclerc, B., Porion, P., Evesque, P., Couarraze, G., Tchoreloff, P., 2006. Compaction behavior and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients. Eur. J. Pharm. Biophar. 64, 66-74.   DOI
73 Cahyadi, C., Chan, L.W., Colombo, P., Heng, P.W.S., 2011. The butterfly effect: A physical phenomenon of hypromellose matrices during dissolution and the factors affecting its occurrence. Int. J. Pharm. 406, 31-40.   DOI
74 Chien, Y.W., 1982. Fundamentals of controlled-release of drug administration, in: J. Swarbrick (Ed.), Novel Drug Delivery System, Marcel Dekker, New York, pp. 465-574.
75 Cobby, J., Mayersohn, M. and Walker, G.C., 1974a. Influence of shape factors on kinetics ofdrug release from matrix tablets. I: theoretical. J.Pharm.Sci.63: 724-731.
76 Anuar, M.S., Briscoe, B.J., 2010. Interfacial elastic relaxation during the ejection of bi-layered tablets. Int. J. Pharm. 387, 42-47.   DOI
77 Abdul, S., Poddar, S.S., 2004. A flexible technology for modified release of drugs: multi layered tablets. J. Control. Release 97, 393-405.   DOI
78 Anuar, M.S., Briscoe, B.J., 2009. The elastic relaxation of starch tablets during ejection. Powder Technol. 195, 96-104.   DOI